http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BG-108302-U

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8f058a71899e153cedc18883bad5b31a
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
filingDate 2003-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7b14db6be6e55b804998e444d26514d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c005b15d1a51d1c5b1d8b583c037d151
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21eaa7eda86ad12013ce1d4bb4c4f2c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21b11c61f8287a80c36ab84e41f03b9b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cbaec074e87d6bfee7614f10bbb23c53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58e9f26d34947b91155306b8753aa4c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89699a6eb807f4f1c79b718c793ca09e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a947852fb2a3a425f05d96f316b32b80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce0497b9b1ef633d3d0364a9cba40a3f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2c20ff75c0a8c9cd8fd4ae661031d21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9b8001a71645b2d1a0fd1a758865838
publicationDate 2005-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BG-108302-U
titleOfInvention PHARMACEUTICAL FORM OF SEED
abstract The drug form is a sublingual tablet that is used for nervous and emotional agitation, migraine, neurasthenia, hysteria, physical and mental overwork, heart neurosis. One tablet contains the following components in g: 25-30% menthol solution in isovaleric acid mesylate ester 0.030-0.080, sorbitol 0.500-1.500, sucrose 0.050-0.500, magnesium carbonate 0.010-0.100 and magnesium stearate 0.010-0.100 . Full adsorption of the active substance is provided by the excipients and the active substance content is kept within the admissible limits for 2 years and has good taste properties. Colloidal silicon dioxide is avoided and magnesium ions released in the stomach have a favorable effect on cardiac activity and nervous mediation and complement the effect of the active substance. a
priorityDate 2003-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11029
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16666
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5988
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82170
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585166
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5780
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454570538
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408978443
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490943
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527785
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10430
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556620
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449454525

Total number of triples: 36.